ACE and prediabetes syndrome: Patients with prediabetes or type 2 diabetes were more often using anti-ischemic medication, lipid-lowering medication, antithrombotic medication, and angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB), compared with non-diabetic patients.